114 related articles for article (PubMed ID: 32520466)
1. [Not Available].
Fumeaux T
Rev Med Suisse; 2020 Jun; 16(697):1220. PubMed ID: 32520466
[No Abstract] [Full Text] [Related]
2. A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir.
Liang C; Tian L; Liu Y; Hui N; Qiao G; Li H; Shi Z; Tang Y; Zhang D; Xie X; Zhao X
Eur J Med Chem; 2020 Sep; 201():112527. PubMed ID: 32563812
[TBL] [Abstract][Full Text] [Related]
3. When the Others Become Us: A Chemist's Perspective of the COVID-19 Outbreak in Italy.
Kiessling L; MacLaughlin C; Sattin S
ACS Chem Biol; 2020 Jun; 15(6):1279-1281. PubMed ID: 32383582
[No Abstract] [Full Text] [Related]
4. Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir.
Jockusch S; Tao C; Li X; Chien M; Kumar S; Morozova I; Kalachikov S; Russo JJ; Ju J
Sci Rep; 2020 Oct; 10(1):16577. PubMed ID: 33024223
[TBL] [Abstract][Full Text] [Related]
5. Drug repositioning is an alternative for the treatment of coronavirus COVID-19.
Serafin MB; Bottega A; Foletto VS; da Rosa TF; Hörner A; Hörner R
Int J Antimicrob Agents; 2020 Jun; 55(6):105969. PubMed ID: 32278811
[TBL] [Abstract][Full Text] [Related]
6. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2.
Williamson BN; Feldmann F; Schwarz B; Meade-White K; Porter DP; Schulz J; van Doremalen N; Leighton I; Yinda CK; Pérez-Pérez L; Okumura A; Lovaglio J; Hanley PW; Saturday G; Bosio CM; Anzick S; Barbian K; Cihlar T; Martens C; Scott DP; Munster VJ; de Wit E
Nature; 2020 Sep; 585(7824):273-276. PubMed ID: 32516797
[TBL] [Abstract][Full Text] [Related]
7. Current pharmacological treatments for SARS-COV-2: A narrative review.
Nittari G; Pallotta G; Amenta F; Tayebati SK
Eur J Pharmacol; 2020 Sep; 882():173328. PubMed ID: 32603692
[TBL] [Abstract][Full Text] [Related]
8. Case report study of the first five COVID-19 patients treated with remdesivir in France.
Dubert M; Visseaux B; Isernia V; Bouadma L; Deconinck L; Patrier J; Wicky PH; Le Pluart D; Kramer L; Rioux C; Le Hingrat Q; Houhou-Fidouh N; Yazdanpanah Y; Ghosn J; Lescure FX
Int J Infect Dis; 2020 Sep; 98():290-293. PubMed ID: 32619764
[TBL] [Abstract][Full Text] [Related]
9. Potential therapeutic agents against COVID-19: What we know so far.
Lu CC; Chen MY; Lee WS; Chang YL
J Chin Med Assoc; 2020 Jun; 83(6):534-536. PubMed ID: 32243270
[TBL] [Abstract][Full Text] [Related]
10. Using "old" medications to fight new COVID-19: Re-purposing with a purpose.
Wang Y; Foo R; Thum T
J Mol Cell Cardiol; 2020 Sep; 146():41-42. PubMed ID: 32687852
[No Abstract] [Full Text] [Related]
11. Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy.
Helleberg M; Niemann CU; Moestrup KS; Kirk O; Lebech AM; Lane C; Lundgren J
J Infect Dis; 2020 Sep; 222(7):1103-1107. PubMed ID: 32702095
[TBL] [Abstract][Full Text] [Related]
12. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence.
Cao YC; Deng QX; Dai SX
Travel Med Infect Dis; 2020; 35():101647. PubMed ID: 32247927
[TBL] [Abstract][Full Text] [Related]
13. Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China.
Pan X; Dong L; Yang L; Chen D; Peng C
Virus Res; 2020 Sep; 286():198057. PubMed ID: 32531236
[TBL] [Abstract][Full Text] [Related]
14. Investigational Therapies for the Treatment of COVID-19: Updates from Ongoing Clinical Trials.
Abrams-Downey A; Saabiye J; Vidaurrazaga M
Eur Urol Focus; 2020 Sep; 6(5):1028-1031. PubMed ID: 32563675
[No Abstract] [Full Text] [Related]
15. Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2.
Dobrovolny HM
Virology; 2020 Nov; 550():61-69. PubMed ID: 32882638
[TBL] [Abstract][Full Text] [Related]
16. Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice.
Wang J; Shuai L; Wang C; Liu R; He X; Zhang X; Sun Z; Shan D; Ge J; Wang X; Hua R; Zhong G; Wen Z; Bu Z
Protein Cell; 2020 Oct; 11(10):776-782. PubMed ID: 32749592
[No Abstract] [Full Text] [Related]
17. Medical treatment options for COVID-19.
Delang L; Neyts J
Eur Heart J Acute Cardiovasc Care; 2020 Apr; 9(3):209-214. PubMed ID: 32363880
[TBL] [Abstract][Full Text] [Related]
18. COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons.
Nile SH; Nile A; Qiu J; Li L; Jia X; Kai G
Cytokine Growth Factor Rev; 2020 Jun; 53():66-70. PubMed ID: 32418715
[TBL] [Abstract][Full Text] [Related]
19. Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions.
Jogalekar MP; Veerabathini A; Gangadaran P
Exp Biol Med (Maywood); 2020 Jun; 245(11):964-969. PubMed ID: 32306751
[TBL] [Abstract][Full Text] [Related]
20. Use of remdesivir for pregnant patients with severe novel coronavirus disease 2019.
Igbinosa I; Miller S; Bianco K; Nelson J; Kappagoda S; Blackburn BG; Grant P; Subramanian A; Lyell DJ; El-Sayed YY; Aziz N
Am J Obstet Gynecol; 2020 Nov; 223(5):768-770. PubMed ID: 32771381
[No Abstract] [Full Text] [Related]
[Next] [New Search]